JuneBrain secures investment for neurotech expansion

Startup develops AI-powered headsets to monitor neurological diseases

Apr. 3, 2026 at 4:06pm

Got story updates? Submit your updates here. ›

A highly detailed, glowing 3D macro illustration of a futuristic neural headset device with intricate circuitry and neon cyan and magenta lights, representing the advanced technology behind JuneBrain's neurological monitoring system.JuneBrain's AI-powered headset technology aims to revolutionize early detection and monitoring of neurological diseases, empowering patients and healthcare providers with advanced data insights.New Orleans Today

Neurotech startup JuneBrain has landed a joint investment from The New Orleans BioFund and the Gulf South Angels to advance its AI-driven technology for remotely monitoring neurological conditions like multiple sclerosis, Parkinson's, and Alzheimer's disease. The funding will support JuneBrain's expansion and partnerships across Louisiana healthcare systems.

Why it matters

JuneBrain's innovative headsets utilizing optical coherence tomography (OCT) software represent a breakthrough in early detection and remote monitoring of neurological diseases. This technology has the potential to significantly improve patient outcomes by enabling more proactive and personalized care, especially in underserved communities.

The details

JuneBrain has designed portable headsets that leverage AI-powered OCT imaging to track eye and neurological symptoms in patients diagnosed with multiple sclerosis, Parkinson's, and Alzheimer's. The joint investment from The New Orleans BioFund and Gulf South Angels will allow the company to accelerate product development, expand access to its technology, and deepen its partnerships with healthcare systems and universities across Louisiana.

  • In 2025, JuneBrain placed first in the BioChallenge Pitch Competition powered by the New Orleans BioInnovation Center (NOBIC).
  • The joint investment from The New Orleans BioFund and Gulf South Angels was announced on April 3, 2026.

The players

JuneBrain

A neurotech startup company that has developed innovative portable headsets utilizing AI-powered optical coherence tomography (OCT) to remotely monitor neurological diseases like multiple sclerosis, Parkinson's, and Alzheimer's.

The New Orleans BioFund

A venture capital fund that invests in early-stage life sciences and biotech startups, with a focus on supporting companies that can improve patient outcomes and build Louisiana's life sciences economy.

Gulf South Angels

An angel investor network that provides funding and strategic support to high-potential startups in the Gulf South region, including Louisiana.

Dr. Samantha Scott

The founder of JuneBrain, who is focused on enhancing retinal imaging technology to advance improved patient outcomes for neurological diseases.

Kris Khalil

The managing director of The New Orleans BioFund, which believes JuneBrain's technology can change patient outcomes at scale.

Got photos? Submit your photos here. ›

What they’re saying

“JuneBrain represents exactly the kind of company BioChallenge was built to champion, a team using cutting-edge AI to solve a real clinical gap in how we detect and monitor neurological disease. We believe this technology can change patient outcomes at scale. We will improve patient outcomes and build a strong life sciences economy in Louisiana one bold investment at a time.”

— Kris Khalil, Managing Director, The New Orleans BioFund

“Our members were impressed by JuneBrain's combination of breakthrough technology and strong market potential. Investments like this reflect our commitment to supporting high-potential companies and partnering with organizations like NOBIC to bring innovative ventures into the Gulf South's expanding entrepreneurial ecosystem.”

— Mike Eckert, Board Chairman, Gulf South Angels

“From our experience at BioChallenge to the ongoing support from GSA and NOBIC, the New Orleans startup community has welcomed us with open arms. This funding allows us to accelerate development, expand access to our technology, and continue building meaningful roots in Louisiana as we grow.”

— Dr. Samantha Scott, Founder, JuneBrain

What’s next

The partnership signifies the expansion of strategic collaborations with health care systems and universities across Louisiana, which will allow JuneBrain to further develop and deploy its innovative neurological monitoring technology.

The takeaway

JuneBrain's AI-powered headsets represent a significant breakthrough in early detection and remote monitoring of neurological diseases, with the potential to dramatically improve patient outcomes, especially in underserved communities. The investment from The New Orleans BioFund and Gulf South Angels will enable the company to accelerate its growth and deepen its roots in Louisiana's thriving life sciences ecosystem.